Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

NCT00727129 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 495

Last updated 2008-09-26

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.

Conditions

  • Postmenopausal Symptoms

Interventions

DRUG

Divigel

Sponsors & Collaborators

  • Upsher-Smith Laboratories

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2005-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00727129 on ClinicalTrials.gov